Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Relationship between clonal evolution and drug resistance in bladder cancer: A genomic research review

13 Jul 2024

Abstract excerpt

Bladder cancer stands as a prevalent global malignancy, exhibiting notable sex-based variations in both incidence and prognosis. Despite substantial strides in therapeutic approaches, the formidable challenge of drug resistance persists. The genomic landscape of bladder cancer, characterized by intricate clonal heterogeneity, emerges as a pivotal determinant in fostering this resistance. Clonal evolution,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Cancer Genomics and Diagnostics
Share to Epigenetics and DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39004242
DOI: 10.1016/j.phrs.2024.107302

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Relationship between clonal evolution and drug resistance in bladder cancer: A genomic research reviewPMID 39004242Read ↗

Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomesSemantic proximity Read ↗

Clonal evolution of chemotherapy-resistant urothelial carcinoma.Semantic proximity Read ↗

Longitudinal Analyses of Mutational Subclonal Architecture and Tumor Subtypes in Recurrent Bladder Cancer.Semantic proximity Read ↗

Paired Exome Analysis Reveals Clonal Evolution and Potential Therapeutic Targets in Urothelial Carcinoma.Semantic proximity Read ↗

Evolution of Urothelial Bladder Cancer in the Context of Molecular ClassificationsSemantic proximity Read ↗

Molecular profile of bladder cancer progression to clinically aggressive subtypesSemantic proximity Read ↗

Oligoclonality in Bladder Cancer:: The Implication for Molecular TherapiesSemantic proximity Read ↗

Single-cell sequencing analysis characterizes common and cell-lineage-specific mutations in a muscle-invasive bladder cancerSemantic proximity Read ↗

Treatment resistance in urothelial carcinoma: an evolutionary perspective.Semantic proximity Read ↗

Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer.Semantic proximity Read ↗

Bladder cancer organoids as a functional system to model different disease stages and therapy responseSemantic proximity Read ↗

Mutation signatures to Pan-Cancer Atlas: Investigation of the genomic landscape of muscle-invasive bladder cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.